AJNN
Academic Journal of Neurology and Neurosurgery

The Academic Journal of Neurology and Neurosurgery deals with Neurology and Neurosurgery accepts articles on these topics. Academic Journal of Neurology and Neurosurgery publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements.

eISSN: 3023-6517
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
The impact of high dose corticosteroid treatment affect on cardiac abnormalities in patients with multiple sclerosis
Abstract
Aims: High-dose corticosteroids to control acute relapses of multiple sclerosis, leveraging their anti-inflammatory effects. However, these treatments can lead to cardiovascular side effects. Understanding the pathophysiology of corticosteroid induced bradycardia is paramount for healthcare providers. Our aim in this study are to identify risk factors for cardiac side effects and assess the timing of cardiac complications relative to treatment.
Methods: Patients who met the McDonald's criteria for definite MS and patients requiring admission for pulse steroid treatment with an acute recurrence were included.Individuals taking cardiac medications, or with a heart illness were excluded.Patients were given 1 g IV methylprednisolone in 2 hours for five to seven days in order to treat acute relapses.
Results: We studied with 23 patients(6 males and 17 females, 26.1/73.9% respectively).The mean±SD age of the patients was 34.6±9.9 (18-43) years and the mean±SD duration of disease was 5.5±4.9 years.Most of the patients were relapsing–remitting MS in 73.9%, primary progressive in 4.4% and secondary progressive in 21.7%.The most common cardiac arhythmia during corticosteroid pulse therapy was sinus bradycradia(n=6).
Conclusion: The combination of direct effects on cardiac myocytes, electrolyte disturbances, autonomic dysfunction, and individual genetic factors can contribute to the development of bradycardia in MS patients treated with high-dose methylprednisolone. Close monitoring and prompt intervention are crucial to manage this adverse effect and optimize patient safety.

Keywords : Multiple sclerosis, pulse corticosteroid, bradicardia

Download Article


1. Cheng W, Li Y, Cui L, et al. Efficacy and safety of corticosteroid treatment in patients with COVID-19: a systematic review and meta-analysis. <em>Front Pharmacol</em>. 2020;11:571156. doi: 10.3389/fphar.2020.571156
2. Otero-Romero S, Lebrun-Fr&eacute;nay C, Reyes S, et al.ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: improving immunization strategies in the era of highly active immunotherapeutic drugs. <em>Mult Scler</em>. 2023;29(8):904-925. doi: 10.1177/13524585231168043
3. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. <em>Lancet Neurol</em>. 2018;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2
4. Filippini G, Brusaferri F, Sibley WA, et al. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. <em>Cochrane Database Syst Rev</em>. 2000;2000(4):CD001331. doi: 10.1002/14651858.CD001331
5. Vettori S, Maresca L, Cuomo G, Abbadessa S, Leonardo G, Valentini G. Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment. <em>Scand J Rheumatol</em>. 2010;39(6):485-9. doi: 10.3109/03009741003781985
6. Albuquerque LDS, Damasceno NRT, Maia FN, et al. Cardiovascular risk estimated in individuals with multiple sclerosis: a case-control study. <em>Mult Scler Relat Disord</em>. 2021;54:103133. doi: 10.1016/j.msard.2021.103133
7. Miqdad MA, Mohamad A, Ali F, Mourad AR, Alamri A. Methylprednisolone-induced symptomatic sinus bradycardia in a multiple sclerosis patient: a case report. <em>Cureus</em>. 2022;14(1):e21443. doi: 10.7759/cureus.21443
8. Stroeder J, Evans C, Mansell H. Corticosteroid-induced bradycardia: Case report and review of the literature. <em>Can Pharm J (Ott).</em> 2015;148(5):235-40. doi: 10.1177/1715163515597451
9. Buchman AL. Side effects of corticosteroid therapy. <em>J Clin Gastroenterol</em>. 2001;33(4):289-94. doi:10.1097/00004836-200110000-00006
10. Myhr KM, Mellgren SI. Corticosteroids in the treatment of multiple sclerosis. <em>Acta Neurol Scand Suppl</em>. 2009;(189):73-80. doi:10.1111/j.1600-0404.2009.01213.x
11. Noetzlin S, Breville G, Seebach JD, Gastaldi G. Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach. <em>Swiss Med Wkly</em>. 2022;152:w30088. doi:10.4414/smw.2022.w30088
12. Sakamoto N, Sato N, Goto M, et al. Three cases of corticosteroid therapy triggering ventricular fibrillation in J-wave syndromes. <em>Heart Vessels</em>. 2014;29(6):867-72. doi: 10.1007/s00380-013-0443-x Epub 2013 Nov 27.
13. Hall ED, Plaster M, Braughler JM. Acute cardiovascular response to a single large intravenous dose of methylprednisolone and its effects on the responses to norepinephrine and isoproterenol. <em>Proc Soc Exp Biol Med.</em> 1983;173(3):338-43. doi: 10.3181/00379727-173-41653
14. Akikusa JD, Feldman BM, Gross GJ, Silverman ED, Schneider R. Sinus bradycardia after intravenous pulse methylprednisolone. <em>Pediatrics</em>. 2007;119(3):e778-82. doi: 10.1542/peds.2006-0029 Epub 2007 Feb 16.
15. Lucas KG, Howrie DL, Phebus CK. Cardiorespiratory decompensation following methylprednisolone administration. <em>Pediatr Hematol Oncol</em>. 1993;10(3):249-55. doi: 10.3109/08880019309029492
16. Walker BR. Glucocorticoids and cardiovascular disease. <em>Eur J Endocrinol</em>. 2007;157(5):545-59. doi: 10.1530/EJE-07-0455
Article available in :
Volume 1, Issue 4, 2024
Page : 68-72
https://doi.org/10.51271/AJNN-0016
Article Information
Received : 12 Eyl 2024
Accepted : 17 Eki 2024
Published : 29 Eki 2024
Corresponding Author :

Ceyhun Sayman: Department of Neurology, Alanya Training and Research Hospital, Alaaddin Keykubat University, Antalya, Turkiye

[email protected]
Citation : Sayman C, Güneş S, Türk O, et al. The impact of high dose corticosteroid treatment affect on cardiac abnormalities in patients with multiple sclerosis . Acad J Neurol Neurosurg. 2024;1(4):68-72.

Read: 49
Cited: 0
Download : 21
_Footer